Abstract
Objectives
Candida albicans is a common fungal infection and is commensal in 40–65 % of healthy adults. The development and pharmacokinetics of a novel sustained release clotrimazole varnish (Clot-SRV) for topical oral use have been reported. The aim of this study was to compare the efficacy of this varnish with clotrimazole troche treatment of oral candidiasis.
Materials and methods
Of the 12 patients with denture stomatitis treated for 14 days, six used Clot-SRV (study group) and six clotrimazole troches (control). The patients were instructed to use Clot-SRV (50 mg of clotrimazole) once a day, and the control group was instructed to use five troches of 10 mg clotrimazole/day. Microbiological samples were obtained from saliva, buccal mucosa, palate, and denture. The degree of erythema was recorded at three time points, and subjective opinions noted using a questionnaire.
Results
At the end of the study, the control group had relatively more cases of erythema on all examined surfaces; patients who applied the Clot-SRV had significantly lower levels of candida on the denture surfaces and in saliva, and had better compliance to the medication.
Conclusions
The novel clotrimazole sustained release varnish may be an important part of a new protocol for oral candidiasis, with improved clinical outcomes.
Similar content being viewed by others
References
Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678
Ellepola ANB, Samaranayake LP (2000) Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 11:172–198
Zegarelli DJ (1993) Fungal infections of the oral cavity. Otolaryngol Clin North Am 26:1069–1089
Gonsalves WC, Wrightson AS, Henry RG (2008) Common oral conditions in older persons. Am Fam Physician 78:845–852
Samaranayake LP, Cheung L, Samaranayake YH (2002) Candidiasis and other fungal diseases of the mouth. Dermatol Ther 15:251–269
van Roey J, Haxaire M, Kamya M, Lwanga I, Katabira E (2004) Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr 35:144–150
Köstler WJ, Hejna M, Wenzel C, Zielinski CC (2001) Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 51:290–315
Ruskin JD, Wood RP, Bailey MR, Whitmore CK, Shaw BW (1992) Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surg Oral Med Oral Pathol 74:567–571
Worthington HV, Clarkson JE (2002) Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy: Cochrane systematic review. J Dent Educ 66:903–910
Vyas SP, Sihorkar V, Mishra V (2000) Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases. J Clin Pharm Ther 25:21–42
Steinberg D, Tal T, Friedman M (2006) Sustained-release delivery systems of triclosan for treatment of Streptococcus mutans biofilm. J Biomed Mater Res B Appl Biomater 77:282–286
Friedman M, Steinberg D (1990) Sustained-release delivery systems for treatment of dental diseases. Pharm Res 7:313–317
Steinberg D, Moldovan M, Molukandov D (2001) Testing a degradable topical varnish of cetylpyridinium chloride in an experimental dental biofilm model. J Antimicrob Chemother 48:241–243
Steinberg D, Rozen R, Klausner EA, Zachs B, Friedman M (2002) Formulation, development and characterization of sustained release varnishes containing amine and stannous fluorides. Caries Res 36:411–416
Czerninski R, Sivan S, Steinberg D, Gati I, Kagan L, Friedman M (2010) A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis. Clin Oral Invest 14:71–78
Marcos-Arias C, Vicente JL, Sahand IH, Eguia A, De-Juan A, Madariaga L, Aguirre JM, Eraso E, Quindós G (2009) Isolation of Candida dubliniensis in denture stomatitis. Arch Oral Biol 54:127–131
Navazesh M, Kumar SKS (2008) Measuring salivary flow. Challenges and opportunities. JADA 139:35S–40S
Borhan MK, Mosallaie S, Torkman M (2006) Oral manifestation and salivary alterations in patients with endstage renal disease. J Qazvin Univ Med Sci Heakth Serv 10:17–20
Figueiral MH, Azul A, Pinto E, Fonseca PA, Branco FM, Scully C (2007) Denture-related stomatitis: identification of aetiological and predisposing factors—a large cohort. J Oral Rehabil 34:448–455
Haveman CW (2004) Xerostomia management in the head and neck radiation patient. Tex Dent J 121:483–497
Mese H, Matsuo R (2007) Salivary secretion, taste and hyposalivation. J Oral Rehabil 34:711–723
Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR (1999) Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. AIDS Res Hum Retroviruses 15:1619–1623
Dias AP, Samaranayake LP, Lee MT (1997) Miconazole lacquer in the treatment of denture stomatitis: clinical and microbiological findings in Chinese patients. Clin Oral Investig 1:47–52
Parvinen T, Kokko J, Yli-Urpo A (1994) Miconazole lacquer compared with gel in treatment of denture stomatitis. Scand J Dent Res 102:361–366
Salerno C, Pascale M, Contaldo M, Esposito V, Busciolano M, Milillo L, Guida A, Petruzzi M, Serpico R (2011) Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 16:e139–e143
PDR.net. Search for clotrimazole. Available at: http://www.pdr.net/drug-summary/clotrimazole-topical-solution?druglabelid=705#11. Accessed 24 February 2014
Pemberton MN, Oliver RJ, Theaker ED (2004) Miconazole oral gel and drug interactions. Brit Dentl J 196:529–531
Sholapurkar AA, Pai KM, Rao S (2009) Comparison of efficacy of fluconazole mouthrinse and clotrimazole mouthpaint in the treatment of oral candidiasis. Aust Dental J 54:341–346
Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE, Fonseca PA, Figueiral MH (2008) Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals. J Oral Pathol Med 37:587–592
Barbeau J, Seguin J, Goulet JP, de Koninck L, Lalonde B, Rompre P, Deslaurjers N (2003) Reassessing the presence of Candida albicans in denture-related stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:51–59
Silva MM, de Oliveira M, Colombo AL, Sanita PV, Jorge JH, Massucato EMS, Vergani CE (2012) Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol 114:469–479
Pereira- Cenci T, Del Bel Cuty AA, Crielaard W, Ten Cate JM (2008) Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci 16:86–94
Olsen I (1990) Oral adhesion of yeasts. Acta Odontol Scand 48:45–53
World Health Organization (2001) Adherence to long-term therapies: policy for action. WHO/MNC/CCH/01.02
Acknowledgments
This study was partially supported by the P&G Innovation Award.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Czerninski, R., Pikovsky, A., Gati, I. et al. Comparison of the efficacy of a novel sustained release clotrimazole varnish and clotrimazole troches for the treatment of oral candidiasis. Clin Oral Invest 19, 467–473 (2015). https://doi.org/10.1007/s00784-014-1259-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-014-1259-5